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Structured summary  12 
Objective. To assess the utility of abdominal ultrasonography (AUS) in the diagnostic work-up of 13 
dogs with diarrhoea.  14 
Methods.  A retrospective, cross-sectional study based on a referral population of dogs with 15 
diarrhoea was done to test the associations between the clinical signs, use of AUS, results of AUS 16 
and subsequent work-up. The utility of AUS was scored as high, moderate, none or 17 
counterproductive based on review of medical records.  18 
Results. Medical records of 269 dogs were reviewed, of which 149 (55%) dogs had AUS. The most 19 
frequent result of AUS was no ultrasonographic abnormalities affecting the intestine in 65 (44%) 20 
dogs. AUS results were associated with subsequent work-up as follows: no abnormalities on AUS and 21 
dietary trial; focal thickening of the intestinal wall, loss of intestinal wall layers and/or enlarged 22 
abdominal lymph nodes and ultrasound-guided FNA; diffuse thickening of the intestinal wall or 23 
hyperechoic striations in the small intestinal mucosa and endoscopy; and small intestinal foreign 24 
body and coeliotomy. AUS had high utility in only 4 (3%) dogs – two had a portosystemic shunt 25 
identified ultrasonographically, one had a linear foreign body and one had a perforated pyloric ulcer; 26 
in each of these dogs the results of AUS were considered diagnostic without further testing.  AUS 27 
had moderate utility in 56 (38%) dogs and no utility in 79 (53%) dogs. AUS was considered 28 
counterproductive in 10 (7%) dogs because results were either falsely negative or falsely positive. 29 
Impact. These results should prompt clinicians to reconsider routine use of AUS in dogs with 30 
diarrhoea.  31 
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Introduction  32 
Diarrhoea, an increase in volume, frequency and/or water-content of faeces, is a common reason for 33 
dogs to be presented for veterinary consultations. Many causes of diarrhoea have been recognised, 34 
including dietary indiscretion, parasitism, viral or bacterial infections, inflammatory bowel disease 35 
(IBD), lymphangiectasia, gastrointestinal neoplasia and metabolic disorders (Allenspach, 2013). 36 
Although many dogs with acute diarrhoea are managed satisfactorily with empirical treatment, 37 
diagnostic work-up is indicated, particularly in dogs with recurrent or chronic diarrhoea. A wide 38 
range of tests are applicable to diagnosis of diarrhoea, including haematology, serum biochemical 39 
analysis, urinalysis, faecal parasitology, trypsin-like immunoreactivity (for suspected exocrine 40 
pancreatic insufficiency), canine specific pancreatic lipase (for suspected pancreatitis) (Mansfield, 41 
2013), adrenocorticotrophic hormone stimulation test (for suspected hypoadrenocorticism) and 42 
serum folate and cobalamin concentration (to assess proximal and distal small intestinal absorption, 43 
respectively) (Allenspach, 2013). A trial period with an elimination diet or hydrolysed diet is 44 
indicated in dogs with suspected food responsive disease (Burgener et al. 2008, Allenspach, 2013, 45 
Allenspach et al., 2016). Endoscopic biopsies may be useful, particularly in differentiation of IBD 46 
from neoplasia (Allenspach, 2013).  47 
Abdominal ultrasonography (AUS) is frequently used in the diagnostic work-up of dogs with 48 
suspected gastrointestinal disorders (Gaschen, 2011). Previous reports have described the 49 
ultrasonographic appearance of the normal canine gastrointestinal tract (Penninck et al., 1989), 50 
gastrointestinal neoplasia (Myers & Penninck 1994; Penninck et al. 2003), intestinal foreign bodies 51 
(Tidwell & Penninck, 1992), obstruction, enteritis, (Penninck et al., 1990), intussusception (Lamb & 52 
Mantis, 1998) and lymphangiectasia (Kull et al. 2001). There have been numerous ultrasonographic 53 
studies of the intestinal wall, including measurements of intestinal wall thickness (Penninck et al., 54 
1989; Delaney et al. 2003; Gaschen, 2011; Gladwin et al., 2014; Guenther et al., 2014). Increased 55 
thickness of the intestinal wall (Lecoindre et al. 2010) and altered echogenicity of wall layers (Kull et 56 
al. 2001; Penninck et al. 2003; Sutherland-Smith et al. 2007; Gaschen et al., 2008; Lecoindre et al. 57 
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2010; Bota et al. 2016) have been reported in some dogs with diarrhoea; however, Rudorf et al 58 
(2005) found no association between ultrasonographic intestinal wall thickness and either the 59 
histological diagnosis or the response to treatment in dogs with diarrhoea. Gaschen et al (2008) 60 
suggested that mucosal echogenicity may be a more accurate indicator of IBD than intestinal wall 61 
thickness in dogs with chronic diarrhoea.  62 
On the basis of these observations, AUS is frequently used in the diagnostic work-up of dogs with 63 
diarrhoea, particularly those with chronc signs; however, there is a lack of information about the 64 
usefulness of this procedure in clinical practice. In this context, a highly useful diagnostic test would 65 
be sufficiently accurate to make other testing unnecessary and a moderately useful test, if not 66 
diagnostic, would provide information that optimised selection of further tests. A prospective study 67 
of the diagnostic utility of AUS in 87 dogs with chronic diarrhoea (at least three weeks duration) 68 
found that abnormalities were most likely to be detected ultrasonographically in dogs with weight 69 
loss and/or a palpable abdominal or rectal mass (Leib et al., 2012). AUS was classified as vital or 70 
beneficial to the diagnosis in 15% dogs, but in 66% dogs, the same outcome would have occurred 71 
had AUS not been performed (Leib et al., 2012). This study contributed significantly to the debate 72 
about how best to work-up dogs with diarrhoea, but potentially exaggerated the utility of AUS 73 
because cytological diagnosis achieved following ultrasound-guided fine needle aspirates was 74 
classified as an ultrasonographic diagnosis (Leib et al., 2012). Another limitation was that the 75 
ultrasonographic findings were not described.  76 
The aims of the present study was to assess the usefulness of AUS in a referral population of dogs 77 
with diarrhoea by testing the associations between the clinical signs, use of AUS, results of AUS and  78 
subsequent work-up, and by assigning a utility score based on review of medical records. 79 
 80 
Materials and Methods 81 
Medical records of patients first seen at                                                in the 12-month period, from 82 
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December 2014 to November 2015, were searched for dogs whose presenting signs included the 83 
terms diarrhoea, haematochezia or melena. Search included dogs examined by the first-opinion 84 
service and dogs referred for investigation of diarrhoea. Dogs were excluded if diarrhoea was not 85 
the primary presenting sign, for example if a dog with neoplasia developed diarrhoea during a 86 
course of chemotherapy.  87 
Medical records were reviewed by one author (      ) and the following data extracted:  88 
 Patient details – age; gender; breed; body weight (kg); body condition score (/9) 89 
 Reported clinical signs – reported duration of diarrhoea; other clinical signs (vomiting; weight 90 
loss; reduced appetite or lethargy) 91 
 Physical examination findings – signs of abdominal pain; palpable abdominal mass; signs of 92 
hypovolaemia; pyrexia (rectal temperature >39.3C)  93 
 Type of diarrhoea – small intestinal; large intestinal or mixed, as determined by the attending 94 
clinician using published guidelines (Allenspach, 2013)  95 
 Results of serum biochemistry – hypoproteinaemia (total protein <49g/L); hypoalbuminaemia 96 
(albumin <28g/L) hypoglobulinaemia (globulin <14.8g/L); high canine specific pancreatic lipase 97 
(>201μg/L)  98 
 Use of other diagnostic tests – abdominal radiography; computed tomography (CT); magnetic 99 
resonance imaging (MRI); abdominal ultrasound (AUS); ultrasound-guided fine needle aspirates 100 
(FNA); upper gastrointestinal endoscopy and biopsy; colonoscopy and biopsy; coeliotomy and 101 
biopsy; dietary trial 102 
 Diagnosis as determined by the attending clinician – gastroenteritis of unknown aetiology; 103 
inflammatory bowel disease (IBD); protein-losing enteropathy (PLE); dietary indiscretion; 104 
lymphoma; other neoplasia; parasitism; secondary to non-gastrointestinal disease (e.g. chronic 105 
renal disease); undetermined.  106 
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Cases were managed by small animal internal medicine or surgery residents under the supervision of 107 
board certified specialists. Ultrasound scans were done by 4 board-certified radiologists or imaging 108 
residents under their direct observation.  109 
Results of AUS, as recorded in contemporaneous reports, were extracted by a board-certified 110 
veterinary radiologist (     ). The AUS results, results of subsequent tests and the clinical diagnosis in 111 
each case were reviewed jointly by two investigators (           ) reaching a consensus by discussion, 112 
and the utility of AUS was scored as 1 high, 2 moderate, 3 none or 4 counterproductive as follows               113 
:  114 
Score 1: High utility – AUS alone was diagnostic; no further diagnostic testing was necessary.  115 
Score 2: Moderate utility – AUS revealed lesions that could reflect the cause of diarrhoea (e.g. 116 
thickening of the intestinal wall, abnormal pancreas); additional diagnostic testing was necessary for 117 
diagnosis. 118 
Score 3: No utility – AUS was normal and cause of diarrhoea was subsequently shown to be 119 
unassociated with morphologic lesions; or if abnormalities were found by AUS, the findings were 120 
non-specific signs of diarrhoea (e.g. increased volume of fluid in the intestine); or abnormalities 121 
found by AUS were considered unrelated to diarrhoea (e.g. urinary calculi)  122 
Score 4: Counterproductive – AUS was potentially misleading because it was falsely negative (cause 123 
of diarrhoea was subsequently shown to be associated with morphologic lesions found by other 124 
tests); or positive for lesions subsequently proven to be unrelated to diarrhoea, but requiring 125 
additional work-up; or falsely positive.  126 
 127 
Clinical data were summarised using median (range). Associations between the clinical signs, use of 128 
AUS, results of AUS and subsequent work-up were tested by one investigator (      ) using 129 
commercially available software (SPSS, Version 22, IBM Corp, Armony, NY). Associations between 130 
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the likelihood of having an ultrasound performed and patient age, clinical signs, results of serum 131 
biochemistry and type of diarrhoea were tested using binary logistic regression. Associations 132 
between having an ultrasound scan performed and use of further diagnostic tests were also tested 133 
using binary logistic regression. Associations between utility score and patient age, clinical signs, 134 
results of serum biochemistry and type of diarrhoea were also tested using logistic regression. 135 
Results of regression analyses were expressed as odds ratio (OR) and 95% confidence interval (CI). 136 
Results with p<0.05 were considered statistically significant.  137 
 138 
Results 139 
The initial medical record search identified 505 visits for dogs that had diarrhoea as a presenting 140 
sign. Of these, 236 were excluded because they were repeat visits (i.e. the dog first presented before 141 
the inclusion dates) or because diarrhoea was not the main complaint, leaving 269 dogs that met the 142 
inclusion criteria for this study. There were 159 (59%) females (124 spayed and 35 intact) and 110 143 
(41%) males (59 entire and 51 intact). Breeds are summarised in table 1. The most common breeds 144 
were mixed breed dogs (19%) and Labrador retrievers (6%). Median age of these dogs was 5.6 years 145 
(range 1month – 18 years). Median body weight was 14.2kg (range 0.5–65.6kg). On the basis of a 146 
body condition score (BCS) in 115 dogs in which it was recorded, 68 (59%) were considered 147 
underweight (BCS<5) and 15 (13%) were overweight (BCS>5). The median duration of diarrhoea 148 
prior to presentation was 5 days (range 1 day – 6 years). 159 (59%) of dogs had diarrhoea for ≤ 21 149 
days. 39 (15%) of dogs had diarrhoea for > 21 days. In 71 (26%) cases, the duration of diarrhoea was 150 
not recorded.  151 
The clinical signs, physical examination findings and results of serum biochemical analysis are 152 
summarised in table 2. The most prevalent clinical sign, in addition to diarrhoea, was vomiting, 153 
which was reported in 183 (68%) dogs (including 16 with haematemesis). On the basis of their 154 
clinical signs, 110 (41%) dogs were classified as having small intestinal diarrhoea, 67 (25%) had large 155 
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intestinal and 47 (17%) had mixed-bowel diarrhoea.  156 
Dogs that had AUS were significantly more likely to have signs of abdominal pain (OR 2.2, 95% CI 1.2-157 
3.9), melena (OR 3.0, 95% CI 1.1-8.1) and hypoalbuminaemia (OR 5.3, 95% CI 2.3-12.0) than dogs 158 
that did not have AUS.  159 
Further diagnostic testing included AUS in 149 (55%) dogs, abdominal radiography in 15 (6%), CT in 160 
23 (9%), ultrasound-guided fine needle aspirates (FNA) in 18 (7%), upper gastrointestinal endoscopy 161 
and biopsy in 35 (13%), colonoscopy and biopsy in 27 (10%), coeliotomy and biopsy in 11 (4%), 162 
dietary trial in 29 (11%) and bone marrow cytology in 2 (<1%) dogs. AUS had been performed by one 163 
of four radiology residents under the supervision of one of six board certified radiologists.  164 
Dogs that had AUS were significantly more likely to have other diagnostic tests including ultrasound-165 
guided FNA (OR 5.9, 95%CI 1.6-22.3), dietary trial (OR 9.0, 95%CI 2.8-29.1), upper gastrointestinal 166 
endoscopy (OR 45.3, 95%CI 5.8-351.0) and coeliotomy (OR 8.4, 95%CI 1.6-45.4) than dogs that did 167 
not have AUS.  168 
Of 149 dogs that had AUS, no ultrasonographic abnormalities were detected affecting the intestine 169 
in 65 (44%) dogs, intestinal dilatation was reported in 21 (14%), reduced small intestinal motility in 170 
12 (8%), focal intestinal wall thickening in 18 (12%), diffuse intestinal wall thickening in 10 (7%), loss 171 
of intestinal wall layers in 11 (7%), hyperechoic striations in the mucosal layer of the small intestine 172 
in 9 (6%), intestinal mass in 4 (3%) and small intestinal foreign body in 4 (3%). Non-intestinal findings 173 
were peritoneal fluid in 30 (20%) dogs, enlarged abdominal lymph nodes in 29 (19%), pancreatic 174 
abnormalities in 25 (17%), hepatomegaly and/or splenomegaly in 21 (14%), nodule or mass affecting 175 
the liver or spleen in 19 (13%), urinary calculi in 12 (8%), prostatomegaly in 5 (3%), congenital 176 
portosystemic shunt in 2 (1%) and adrenal mass in 2 (1%) dogs. In 41 (28%) dogs no ultrasonographic 177 
abnormalities were identified in the abdomen. The associations between ultrasound findings 178 
pertaining to the gastrointestinal tract and use of further diagnostic tests (n>5) are summarised in 179 
table 3. The following associations were found to be statistically significant: no abnormalities on AUS 180 
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and dietary trial (p=0.02); focal thickening of the intestinal wall and ultrasound-guided FNA (p=0.02); 181 
diffuse thickening of the intestinal wall and colonoscopy (p=0.02); loss of intestinal wall layers and 182 
ultrasound-guided FNA (p<0.001); hyperechoic striations in the small intestinal mucosa and upper 183 
gastrointestinal endoscopy, colonoscopy and both (p=0.01); small intestinal foreign body and 184 
coeliotomy (p=0.02); enlarged abdominal lymph nodes and ultrasound-guided FNA (p<0.001).  185 
Clinical diagnoses were recorded as follows: gastroenteritis with unknown aetiology in 102 (38%) 186 
dogs, IBD in 44 (16%), PLE in 25 (9%) dietary indiscretion in 18 (7%), pancreatitis in 16 (6%), 187 
lymphoma in 11 (4%), other neoplasia in 9 (3%), chronic renal disease in 6 (2%), colitis or typhlitis in 188 
6 (2%), immune-mediated disease in 5 (2%), parasitism in 3 (1%) and portosystemic shunt  in 3 (1%). 189 
There were single instances of other specific diagnoses in 8 (3%) dogs. In the remaining 13 dogs (9%) 190 
a final diagnosis was not recorded.  191 
Dogs that had AUS were significantly more likely to have a diagnosis of IBD (OR 6.4, 95% CI 2.1-19.3) 192 
or pancreatitis (OR 4.9, 95% CI 1.1-23.2) and significantly less likely to have a diagnosis of 193 
gastroenteritis (OR 0.3, 95% CI 0.09-0.5) than dogs that did not have AUS.  194 
Of 11 dogs that had intestinal lymphoma, 7 had AUS and, of these, 3 (43%) had no abnormalities, 2 195 
(29%) had diffuse intestinal wall thickening with loss of layers and enlarged abdominal lymph nodes, 196 
1 (14%) had focal intestinal wall thickening and enlarged abdominal lymph nodes, and 1 (14%) had 197 
hepatic and splenic nodules, enlarged abdominal lymph nodes and peritoneal fluid.  198 
The utility score assigned to AUS was 1 (diagnostic) in 4 (3%) dogs. Two of these had a portosystemic 199 
shunt identified ultrasonographically, one dog had a linear foreign body and one dog had a 200 
perforated pyloric ulcer; in each of these dogs the results of AUS were considered diagnostic.  The 201 
utility score was 2 in 56 (37%) dogs, 3 in 79 (53%) dogs and 4 in 10 (7%) dogs.  Of the 10 dogs with 202 
utility score 4 (counterproductive), 3 had an abdominal mass that required further work-up but was 203 
unrelated to the cause of diarrhoea, 3 had no abnormalities on AUS but diagnosis of intestinal 204 
lymphoma on subsequent endoscopic biopsies, 2 had pancreatic abnormalities reported on AUS but 205 
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no other clinical or pathological findings to suggest pancreatic disease, and 2 were reported as 206 
having diffuse intestinal wall thickening and enlarged abdominal lymph nodes on AUS but 207 
subsequent testing supported diagnosis of food-responsive diarrhoea and hepatic toxicity, 208 
respectively. No significant associations were found between utility score and patient age, clinical 209 
signs, results of serum biochemistry and type of diarrhoea.  210 
 211 
Discussion 212 
AUS was performed in just over half of the dogs presented to our hospital primarily for diagnostic 213 
work-up of diarrhoea in a 12-month period. Multiple additional clinical signs were reported in many 214 
instances, hence the indication for AUS was based on more than just diarrhoea. Dogs with 215 
abdominal pain, melena or hypoalbuminaemia were more likely to have AUS included in their work-216 
up than dogs lacking these signs. These results likely represent decisions by clinicians that AUS is 217 
indicated to look for signs of pancreatitis, a bleeding ulcer or neoplasia, or reasons for protein-losing 218 
enteropathy, respectively. Other patient variables, including age, duration of signs and occurrence of 219 
vomiting or weight loss, were not significantly associated with use of AUS.  220 
Dogs that had AUS were significantly more likely to have multiple other diagnostic tests, including 221 
ultrasound-guided FNA, dietary trial, upper gastrointestinal endoscopy and coeliotomy than dogs 222 
that did not have AUS. This result is compatible with the observation that in dogs with diarrhoea AUS 223 
usually finds either no abnormalities or non-specific abnormalities requiring further investigation. In 224 
referral practices, AUS is routinely used in the diagnostic work-up of dogs with chronic diarrhoea not 225 
because it is liable to be diagnostic, but because it may help determine if the small or large intestine 226 
is the affected and if there are mass lesions requiring surgical treatment (Allenspach, 2013). 227 
Diagnosis of gastroenteritis was more frequent in dogs that did not have AUS. This finding likely 228 
reflects the fact that this is a non-specific diagnosis, most likely to be applied to dogs with more 229 
acute and/or self-limiting clinical signs for which a diagnostic work-up was considered unnecessary.  230 
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Associations were found in the present study between finding focal thickening of the intestinal wall 231 
and ultrasound-guided FNA, and between finding a small intestinal foreign body by AUS and 232 
subsequent coeliotomy, which support this approach; however, finding hyperechoic striations in the 233 
small intestinal mucosa was associated with subsequent upper gastrointestinal endoscopy, 234 
colonoscopy and both. Based on reivew of medical records, it is not clear that the site of abnormality 235 
found on AUS was used to guide the endoscopy; however, in dogs with suspected small intestinal 236 
lesion, colonoscopy is often performed for the purpose of ileoscopy, not to examine the colon per 237 
se. Hence, upper and lower gastrointestinal endoscopy may be employed regardless of ultrasound 238 
findings. Gaschen et al (2008) suggested that increased mucosal echogenicity may be a more 239 
accurate indicator of IBD than intestinal wall thickness in dogs with chronic diarrhoea; however, a 240 
more recent study found that up to 50% normal dogs had hyperechoic foci in the intestinal mucosa if 241 
scanned within 1 hour of a meal (Gaschen et al. 2016). Hence the value of using this finding to help 242 
select further diagnostic tests is doubtful because it may not represent a pathological change.  243 
One potential benefit of abdominal ultrasound is that it can guide clinicians into pursuing a 244 
therapeutic trial rather than more invasive tests (Leib et al., 2012), but it is not known how 245 
frequently this occurs. Ultrasonography is non-invasive, safe and does not require general 246 
anaesthesia, but it is a relatively expensive test and dogs with diarrhoea have a relatively low 247 
probability of morphological lesions to explain their disease, which means the indication for AUS is 248 
weak (Weinstein et al. 2005). AUS lacked utility in half the dogs in the present series. A large 249 
proportion of dogs (44%) had no ultrasonographic findings pertinent to the gastrointestinal tract and 250 
many more had non-specific findings, the significance of which could only be determined by other 251 
tests. Several large studies found that most dogs presenting with chronic diarrhoea are food 252 
responsive (A;lenspach JVIM 2008 and Allenspach Vet Rec 2016), hence it is therefore advisable that 253 
all dogs with chronic diarhoea undergo a food trial as an initial step in their diagnostic workup.  254 
AUS indicated a specific cause for diarrhoea in only 3% dogs in the present series. This result may be 255 
compared with that of Leib et al. (2012) who considered AUS to be vital to diagnosis in 10% dogs 256 
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with diarrhoea of greater than 3 weeks duration, although that figure included cases in which the 257 
diagnosis was obtained by ultrasound-guided FNA or biopsy rather than by ultrasonography per se. 258 
In their study of AUS in dogs with diarrhoea, Leib et al. (2012) found that increased diagnostic utility 259 
of AUS was associated with palpation of an abdominal or rectal mass or weight loss, but the present 260 
study did not reproduce these results. Only 3% dogs in the present study had a palpable abdominal 261 
mass, compared to 7% in the study by Leib et al. (2012). No significant associations were found in 262 
the present study between utility score and patient age, clinical signs, results of serum biochemistry 263 
and type of diarrhoea, hence it is not possible to make specific recommendations about which dogs 264 
with diarrhoea are the best candidates for AUS.  265 
The importance of finding such a low frequency of ultrasonographic diagnosis is that it should 266 
prompt clinicians to reconsider routine use of AUS in dogs with diarrhoea, especially in acute cases 267 
without systemic signs, and in chronic cases with mild clinical severity (Allenspach et al. 2016). Utility 268 
scores 2 and 3, representing dogs with non-specific or negative findings, accounted for 90% cases in 269 
the present study. If the usual result in dogs with diarrhoea is a negative study or non-specific 270 
findings, it does not represent a good use of resources, particularly since AUS is one of the most 271 
expensive non-invasive diagnostic tests routinely available in veterinary practice. As illustrated in the 272 
present study by the results in dogs with intestinal lymphoma, AUS is not sufficiently sensitive that a 273 
negative study enables specific diagnoses to be ruled out. Furthermore, if our results are 274 
representative, and dogs in which AUS indicated a specific cause for diarrhoea are outnumbered by 275 
those in which is is counterproductive, AUS may be best avoided in the work-up of most dogs with 276 
diarrhoea.  277 
Limitations of this study are related to its retrospective nature. In particular, there was no standard 278 
protocol that dictated the diagnostic work-up. Instead, the case management was determined by 279 
the clinician with the agreement of the owner. Ultrasonography was done by specialist radiologists 280 
working independently without consensus but with knowledge of the clinical history and likely 281 
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differential diagnosis at the time of ultrasonography. Under these circumstances, AUS interpretation 282 
will be subject to inter-observer variations and bias (such as confirmation bias), but such variability 283 
cannot be quantified.  284 
A further limitation was the lack of follow-up of cases, which would have the potential advantage of 285 
increasing confidence in a proportion of the clinical diagnoses. The utility score relied partly on the 286 
diagnosis, as determined by the clinician, hence it is possible that changing the diagnoses based on 287 
findings at follow-up could alter the utility score in some of the affected dogs. However, it is difficult 288 
to envisage an increase in utility score occurring as a result of corrected diagnosis.  289 
We included cases with an open diagnosis or without histological or cytological confirmation of the 290 
diagnosis because such cases represent a meaningful proportion of a diarrhoea caseload and 291 
because lack of a final diagnosis is partly a reflection of the lack of utility of AUS. It should be 292 
emphasised that this study does not enable estimation of the accuracy of AUS for specific diagnoses 293 
because of the inclusion of cases with open or presumptive diagnosis. Without a means to 294 
accurately classify dogs, the accuracy of AUS is unknown.  Nevertheless, the lack of utility of AUS in a 295 
large proportion of dogs in this study should prompt clinicans to reconsider routine use of AUS in 296 
dogs with diarrhoea.  297 
 298 
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Table 1. Summary of breeds 361 
 362 
Breed Number 363 
Mixed breed 50 (19%) 364 
Labrador Retriever 30 (11%) 365 
Jack Russell Terrier 16 (6%) 366 
Staffordshire Bull Terrier 16 (6%) 367 
Cocker Spaniel 14 (5%) 368 
Miniature Schnauzer 10 (4%) 369 
German Shepherd Dog 10 (4%) 370 
Shih-Tzu 7 (3%) 371 
Rottweiler 6 (2%) 372 
Golden Retriever 5 (2%) 373 
Border Collie 4 (1%) 374 
Rhodesian Ridgeback 4 (1%) 375 
Cavalier King Charles Spaniel 4 (1%) 376 
Weimeraner 3 (1%) 377 
Border Terrier 3 (1%) 378 
Cairn Terrier 3 (1%) 379 
Chihuahua 3 (1%) 380 
Cockerpoo 3 (1%) 381 
English Springer Spaniel 3 (1%) 382 
Greyhound 3 (1%) 383 
Hungarian Vizsla 3 (1%) 384 
Miniature Dachshund 3 (1%) 385 
Shar-pei 3 (1%) 386 
Whippet 3 (1%) 387 
Yorkshire Terrier 3 (1%) 388 
  389 
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Table 2. Concurrent clinical signs, physical examination findings and serum chemistry results in dogs 390 
with diarrhoea 391 
 392 
Clinical signs Number 393 
Vomiting 183 (68%) 394 
     Including haematemesis 16 (6%) 395 
Lethargy 106 (39%) 396 
Decreased appetite 88 (33%) 397 
Weight loss 43 (16%) 398 
Melena 30 (11%) 399 
Polyruia/polydipsia 15 (6%) 400 
Regurgitation 12 (4%) 401 
Flatulence or borborygmi 7 (3%) 402 
Physical examination findings   403 
Abdominal pain  72 (27%) 404 
Hypovolaemia 32 (12%) 405 
Pyrexia  17 (6%) 406 
Icterus 7 (3%) 407 
Erythematous skin 6 (2%) 408 
Palpable abdominal mass 6 (2%) 409 
Palpable rectal mass  2 (1%) 410 
Serum chemistry   411 
Panhypoproteinaemia 37 (14%) 412 
Raised cPLi 20 (7%) 413 
Anaemia  13 (5%) 414 
Hypoalbuminaemia 5 (2%) 415 
Hypoglobulinaemia  2 (1%) 416 
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Table 3. Associations between the results of abdominal ultrasound and use of further diagnostic tests (n>5) in 149 dogs with diarrhoea 417 
 Further diagnostic tests       
Results of 
ultrasound
  
Abdominal 
radiography 
n=15 
CT n=8 Ultrasound-
guided fine 
needle 
aspirates n=14 
Upper 
gastrointestina
l endoscopy 
and biopsy 
n=34 
Colonoscopy 
and biopsy 
n=27 
Both upper 
and lower 
gastrointestina
l endoscopy 
n=25 
Coeliotomy 
n=9 
Dietary trial 
n=25
  
No abnormalities 
detected 
7 (47%)  3 (38%)  2 (14%) 16 (47%) 12 (44%)  11 (44%) 1 (11%) 18 (72%)* 
Intestinal dilatation 3 (20%) 0 2 (14%) 2 (6%) 2 (7%) 2 (8%) 3 (33%) 3 (12%) 
Focal intestinal wall 
thickening 
3 (20%) 0 5 (36%)* 2 (6%) 2 (7%) 2 (8%) 3 (3%) 1 (4%) 
Diffuse intestinal wall 
thickening 
0 1 (13%) 1 (7%) 4 (12%) 5 (19%)* 4 (16%) 0 1 (4%) 
Loss of intestinal wall 
layers 
1 (7%) 0 8 (57%)* 0 1 (4%) 0 2 (22%) 1 (4%) 
Hyperechoic striations 
in small intestinal 
mucosa 
0 0 0 7 (21%)* 5 (19%)* 5 (20%)* 0 1 (4%) 
Intestinal mass 0 1 (13%) 1 (7%) 0 0 0 1 (11%) 0 
Small intestinal foreign 
body 
1 (7%) 0 0 1 (3%) 0 0 4 (22%)* 1 (4%) 
Reduced small 
intestinal motility 
3 (20%) 1 (13%) 0 1 (3%) 1 (4%) 1 (4%) 1 (11%) 1 (4%) 
Peritoneal fluid 3 (20%) 1 (13%) 4 (29%) 8 (24%) 7 (26%) 6 (24%) 4 (44%) 2 (8%) 
Enlarged abdominal 
lymph nodes 
3 (20%) 0 9 (64%)* 7 (21%) 7 (26%) 6 (24%) 2 (22%) 2 (8%) 
Pancreatic 
abnormalities 
3 (20%) 3 (38%) 2 (14%) 2 (6%) 2 (6%) 2 (8%) 2 (22%) 3 (12%) 
*p<0.05 418 
